Back to Ask the Diabetes Team Ask the Diabetes Team

From Los Angeles, California, USA:

I read about INGAP therapy. Where can I contact the researchers involved in it? Are there any current human trials for this therapy? What is your opinion?


INGAP or Islet NeoGenesis Associated Protein is a hamster protein which has been shown to increase islet cell mass in both normal animals and young animals with diabetes.

It is probable that any new islet tissue would be vulnerable to destruction in type 1A (autoimmune) diabetes. Whilst not of direct therapeutic interest at the moment, this area of developmental biology may one day provide an important new key to diabetes treatment.

I found out that Eli Lilly had contracted for a human trial that they then cancelled in 1999. However, Procter & Gamble have apparently been persuaded to commit the money, and phase I/II clinical trials are under way.


[Editor's comment: See Procter & Gamble Announces Strategic Alliance With GMP Companies For Novel Treatment Of Diabetes Mellitus. JSH]

Original posting 14 Jul 2003
Posted to Research: Other Research


  Back to Ask the Diabetes Team Return to the Top of This Page

Last Updated: Tuesday April 06, 2010 15:09:46
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.